Patient rights from the perspective of drug-resistant TB patients

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

Standard

Patient rights from the perspective of drug-resistant TB patients. / Seeberg, Jens.

2017. S31 Abstract from 48th Union World Conference on Lung Health, Guadelajara, Mexico.

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

Harvard

Seeberg, J 2017, 'Patient rights from the perspective of drug-resistant TB patients', 48th Union World Conference on Lung Health, Guadelajara, Mexico, 11/10/2017 - 14/10/2017 pp. S31. <http://www.abstractserver.com/TheUnion2017/TheUnion2017_Abstracts_Web.pdf>

APA

CBE

Seeberg J. 2017. Patient rights from the perspective of drug-resistant TB patients. Abstract from 48th Union World Conference on Lung Health, Guadelajara, Mexico.

MLA

Seeberg, Jens Patient rights from the perspective of drug-resistant TB patients. 48th Union World Conference on Lung Health, 11 Oct 2017, Guadelajara, Mexico, Conference abstract for conference, 2017.

Vancouver

Seeberg J. Patient rights from the perspective of drug-resistant TB patients. 2017. Abstract from 48th Union World Conference on Lung Health, Guadelajara, Mexico.

Author

Seeberg, Jens. / Patient rights from the perspective of drug-resistant TB patients. Abstract from 48th Union World Conference on Lung Health, Guadelajara, Mexico.

Bibtex

@conference{19bde28c76904e668924c683bd2428ed,
title = "Patient rights from the perspective of drug-resistant TB patients",
abstract = "Based on long-term dialogues with people affected by drug resistant TB in India, this presentation maps key challenges to the protection of patient rights at various critical points on the pathway from onset of symptoms to XDR development, and relates these challenges to the recent WHO Ethics Guidance document. Porous boundaries between public and private treatment leading to out-of-pocket payment for diagnostics and treatment of poor patients with DRTB raise particularly difficult ethical questions in resource-poor settings.",
author = "Jens Seeberg",
year = "2017",
language = "English",
pages = "S31",
note = "48th Union World Conference on Lung Health ; Conference date: 11-10-2017 Through 14-10-2017",
url = "https://www.theunion.org/what-we-do/conferences/world-conference-on-lung-health/48th-union-world-conference-on-lung-health",

}

RIS

TY - ABST

T1 - Patient rights from the perspective of drug-resistant TB patients

AU - Seeberg, Jens

PY - 2017

Y1 - 2017

N2 - Based on long-term dialogues with people affected by drug resistant TB in India, this presentation maps key challenges to the protection of patient rights at various critical points on the pathway from onset of symptoms to XDR development, and relates these challenges to the recent WHO Ethics Guidance document. Porous boundaries between public and private treatment leading to out-of-pocket payment for diagnostics and treatment of poor patients with DRTB raise particularly difficult ethical questions in resource-poor settings.

AB - Based on long-term dialogues with people affected by drug resistant TB in India, this presentation maps key challenges to the protection of patient rights at various critical points on the pathway from onset of symptoms to XDR development, and relates these challenges to the recent WHO Ethics Guidance document. Porous boundaries between public and private treatment leading to out-of-pocket payment for diagnostics and treatment of poor patients with DRTB raise particularly difficult ethical questions in resource-poor settings.

M3 - Conference abstract for conference

SP - S31

T2 - 48th Union World Conference on Lung Health

Y2 - 11 October 2017 through 14 October 2017

ER -